BofA Securities downgrades Sage Therapeutic to 'neutral' with a price target of $25.00
BofA Securities downgrades Sage Therapeutic to 'neutral' with a price target of $25.00

BofA Securities downgrades Sage Therapeutic to 'neutral' with a price target of $25.00
Source link